Clinical Trial Update: IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of irinotecan and oxaliplatin as adjuvant therapy for high-risk Stage III colon cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: UNICANCER | Conditions: Colon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2) | Phase 3 | Status: COMPLETED